Exosome RNA Exosome RNA Research & Industry News
from San Francisco Business Times by Ron Leuty Guardant Health Inc. snagged nearly $100 million in funding from OrbiMed Advisors and others to aggressively expand its commercial and scientific work as competitors jump into the liquid biopsy market. The Redwood ...
Read More »Liquid biopsy company Guardant Health draws $100 million to sleuth out cancers
